Detalles de la búsqueda
1.
One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma.
BMC Med
; 20(1): 415, 2022 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36310160
2.
A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma.
Cancer Cell Int
; 22(1): 95, 2022 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35193591
3.
Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis.
Cancer Immunol Immunother
; 70(11): 3207-3216, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33813646
4.
Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro.
Cancer Cell Int
; 21(1): 610, 2021 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34794449
5.
NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma.
Cancer Cell Int
; 19: 228, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31516385
6.
Intestinal obstruction due to dual gastrointestinal atresia in infants: diagnosis and management of 3 cases.
BMC Gastroenterol
; 14: 108, 2014 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24928109
7.
Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma.
Front Immunol
; 15: 1260191, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38384459
8.
MZF1 promotes tumour progression and resistance to anti-PD-L1 antibody treatment in hepatocellular carcinoma.
JHEP Rep
; 6(1): 100939, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38074509
9.
Hepatic arterial infusion chemotherapy for patients with hepatocellular carcinoma: Applicability in Western countries.
Curr Opin Pharmacol
; 70: 102362, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36931163
10.
DNA methylation-activated full-length EMX1 facilitates metastasis through EMX1-EGFR-ERK axis in hepatocellular carcinoma.
Cell Death Dis
; 14(11): 769, 2023 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38007497
11.
Lenvatinib, Toripalimab plus FOLFOX Chemotherapy in Hepatocellular Carcinoma Patients with Extrahepatic Metastasis: A Biomolecular Exploratory, Phase II Trial (LTSC).
Clin Cancer Res
; 29(24): 5104-5115, 2023 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37819944
12.
Comprehensive characterization of enhancer RNA in hepatocellular carcinoma reveals three immune subtypes with implications for immunotherapy.
Mol Ther Oncolytics
; 26: 226-244, 2022 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35919459
13.
SP1-induced lncRNA DUBR promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via E2F1-CIP2A feedback.
Cancer Lett
; 528: 16-30, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34958891
14.
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials.
Technol Cancer Res Treat
; 21: 15330338221117389, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36529949
15.
Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway.
J Exp Clin Cancer Res
; 41(1): 5, 2022 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980201
16.
Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial.
Eur J Cancer
; 174: 68-77, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35981413
17.
PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma.
Cancer Res
; 82(18): 3307-3320, 2022 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35802648
18.
Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma.
J Immunother Cancer
; 9(6)2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34168004
19.
Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma.
Front Oncol
; 11: 619461, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34055599
20.
Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma.
Dis Markers
; 2020: 4269460, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32695241